This webinar aims to identify the challenges and opportunities for pharmacists in addressing diabetes, highlight the different ways pharmacists can advocate for increased recognition and visibility of roles in providing diabetes-related services, understand the role that pharmacists can play in achieving global diabetes goals, in commemoration of the 2021 World Diabetes Day (WDD). The event will culminate with the launch of the ONE FIP Practice Transformation Programme on Diabetes.

This event will also close the series of five webinars organised by FIP to explore the role of pharmacists in the prevention and management of diabetes and its complications; the advancement in therapeutic options; the competencies and workforce development opportunities; and the policy barriers and facilitators in providing diabetes-related services.

At the end of this webinar, participants will:
• Identify the challenges and opportunities for pharmacists in addressing diabetes
• Recognize the different ways pharmacists can advocate for increased recognition and visibility of roles in providing diabetes services
• Understand how the role of pharmacists can be elevated in achieving global diabetes goals, in commemoration of the 2021 World Diabetes Day (WDD) 14 November

Moderator:
-Paul Sinclair, FIP Chair Board of Pharmaceutical Practice, Community Pharmacist, Australia

Panelists:
-Tolulope Osigbesan, Advocacy and Partnerships Officer, NCDs Alliance, Switzerland
-Iryna Vlasenko, Vice president International Diabetes Federation, Ukraine
-Jean-Baptiste Nikiema, Regional advisor, EDM, WHO Regional Office for Africa, Republic of Congo
-Gonçalo  Sousa Pinto, FIP Lead for Practice Development and Transformation, Spain
-Lauren Blum, Global engagement fellow, UNC Eshelman School of Pharmacy, USA
-Rúben Viegas,FIP Practice Development Projects Coordinator, Spain
-Aniekan Ekpenyong, Practice Transformation Projects Coordinator FIP, Nigeria
-Michael Donohoe, Global Patient Advocate, A1C Wellness {Diabetes...], USA

This webinar aims to highlight strategies for developing a diabetes competent workforce, explore success stories of countries that have developed competency framework for diabetes-related roles and to identify relevant competencies essential for the delivery of diabetes services by pharmacists.

Around 422 million people worldwide have diabetes and 1. 6 million deaths are directly attributed to diabetes each year. Pharmacists, across all sectors and areas of practice do have a role to play in ensuring the prevention and management of diabetes. In a series of five webinars, the role of pharmacists in the prevention and management of diabetes and its complications; advancement in therapeutic options; competencies and workforce development opportunities; and policy barriers and facilitators in providing diabetes services will be explored. The series culminates in the launching of the ONE FIP Practice Transformation Programme on Diabetes.

At the end of this webinar, participants will:
-Understand the strategies for developing a diabetes competent workforce
-Learn from successful experiences on how to develop competency framework for diabetes related roles
-Identify relevant competencies facilitating the delivery of diabetes-related services

Moderator:
-Ralph Altiere, Chair of FIP Education (FIPEd) University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, USA

Panelists:
- Sallianne Kavanagh, Senior Lecturer- Clinical Pharmacy and Pharmacy Practice. Advanced Clinical Pharmacist. University of Huddersfield. Sheffield Teaching Hospitals NHSFT, United Kingdom
- Andreia Bruno-Tomé,  Global Lead for DG 5 - Competency Development, Senior Expert Strategist, McCann Health, Portugal
- Diana Isaacs, Endocrine Clinical Pharmacy Specialist, Cleveland Clinic, USA

This webinar aims to describe the advancement in diabetes therapeutics for managing diabetes, highlight the role of technology in improving health outcome of individuals living with diabetes and identify the different services employed in the optimization of diabetes treatment.

Around 422 million people worldwide have diabetes and 1. 6 million deaths are directly attributed to diabetes each year. Pharmacists, across all sectors and areas of practice do have a role to play in ensuring the prevention and management of diabetes. In a series of five webinars, the role of pharmacists in the prevention and management of diabetes and its complications; advancement in therapeutic options; competencies and workforce development opportunities; and policy barriers and facilitators in providing diabetes services will be explored. The series culminates in the launching of the ONE FIP Practice Transformation Programme on Diabetes

At the end of this webinar, participants will:

• Describe the advancement in diabetes therapeutics for managing diabetes
• Explain the role of technology in improving health outcome of individuals living with diabetes
• Identify the different services employed in the optimization of diabetes treatment

Moderator:
Ross McKinnon, Chair of BPS, Chair of Board of Pharmaceutical Sciences, FIP Australia

Panelists:
-Antria Pavlidou, YPG PharmSci Promotion, PhD Candidate, Clinical Pharmacist  Pharmaceutical Services, Ministry of Health, Cyprus / PhD Candidate UCL, Cyprus
-Kalyan Venkata, Assistant Professor, Medicinal Chemistry, Pharmaceutical and Administrative Sciences,
University of Health Sciences and Pharmacy in St. Louis, USA
-Anna Busquets Casso, Community pharmacist, SEFAC, Spain

This webinar aims to describe the different services provided by pharmacists to manage diabetes, explore the role of pharmacists in preventing the complications of diabetes, and highlight the importance of collaboration with other health professionals in achieving treatment goals

Around 422 million people worldwide have diabetes and 1. 6 million deaths are directly attributed to diabetes each year. Pharmacists, across all sectors and areas of practice do have a role to play in ensuring the prevention and management of diabetes. In a series of five webinars, the role of pharmacists in the prevention and management of diabetes and its complications; advancement in therapeutic options; competencies and workforce development opportunities; and policy barriers and facilitators in providing diabetes services will be explored. The series culminates in the launching of the ONE FIP Practice Transformation Programme on Diabetes.

At the end of this webinar, participants will:

• Describe the different services provided by pharmacists to manage diabetes
• Identify the role of pharmacists in preventing the complications of diabetes
• Understand the importance of collaboration with other diabetes health professionals in achieving treatment goals

Modarator:
Tim Chen, President FIP Social and Administrative Pharmacy Section,
Australia

Panelists:
-Sanah Hasan, President of FIP Social and Administrative Pharmacy Section, Associate Professor Ajman University, College of Pharmacy and Health Sciences, United Arab Emirates
-Astrid Czock, FIP Global Lead for DG8: Working with others, CEO QualiCCare, Switzerland
-Francisco Javier Jiménez Ramírez, Professor / Pharmacist University of Puerto Rico School of Pharmacy,
Puerto Rico
- Mara Pereira Guerreiro, Invited Professor, Nursing School of Lisbon & Instituto Universitário Egas Moniz Nursing School of Lisbon & Instituto Universitário Egas Moniz, Portugal

Anticoagulant therapy requires appropriate monitoring and management to ensure safety and effectiveness of the treatment, avoid complications and to achieve optimal clinical outcomes. Pharmacists can play an important role in anticoagulation therapy management through their expert knowledge of medicines. This role also includes the provision of patient education, identification of drug interactions, monitoring for dose appropriateness and checking for adverse effects. This webinar will explore the various roles that pharmacists can play in providing anticoagulation management services.

At the end of this webinar, participants will:
1. Identify the different issues impacting anticoagulation management
2. Recognize the crucial role of pharmacists in enhancing the management of anticoagulation
3. Explain the role technology can play in supporting anticoagulation management
4. Describe the barriers and opportunities for pharmacists in leading anticoagulation management services

Moderator:
Carlos Lacava Fernández, Vice President of FIP, Uruguay

Panelists:
-Sahimi Mohamed, Clinical Pharmacist Hospital Serdang, Ministry of Health, Malaysia
-Nida Najmi, Founder of Online Anticoagulation
Management Services & Mahir-e-Adviyat, Pakistan
-Rose Anne, Coordinator, Anticoagulation Stewardship Program, University of Wisconsin Hospital and Health System (UW Health), Madison, Wisconsin, USA

This webinar aims to highlight the different services provided by pharmacists in the prevention, screening and detection of diabetes. It will also demonstrate how pharmacists are providing such services in a time of pandemic.

Around 422 million people worldwide have diabetes and 1. 6 million deaths are directly attributed to diabetes each year. Pharmacists, across all sectors and areas of practice do have a role to play in ensuring the prevention and management of diabetes. In a series of five webinars, the role of pharmacists in the prevention and management of diabetes and its complications; advancement in therapeutic options; competencies and workforce development opportunities; and policy barriers and facilitators in providing diabetes services will be explored. The series culminates in the launching of the ONE FIP Practice Transformation Programme on Diabetes.

At the end of this webinar, participants will:
1. Become familiar with services that pharmacists can provide in promoting the awareness of diabetes and adoption of healthy lifestyle
2. Recognise the role of pharmacists in the screening and detection of diabetes
3. Describe how the pandemic has influenced the delivery of diabetes services by pharmacists.

Moderator:
- Manjiri Gharat, FIP Vice-President, FIP, India

Panellists:
- Paula Teixeira, Scientific Information Manager, Center for Medicines Information and Health Interventions (CEDIME) in the Portuguese National Association of Pharmacies (ANF), Portugal
- Margaret Wonah, Pharmacist, The Diabetes Care Network, Nigeria
- Mohamed Hassan Elnaem, Assistant Professor of Clinical Pharmacy, Department of Pharmacy Practice, Faculty of Pharmacy, International Islamic University, Malaysia